Twenty years of experience with PDD and PDT in Poland-Review

Photodiagnosis and Photodynamic Therapy

Volumn 6, Issue 2, 2009, Pages 73-78

  Sieroń, Aleksander ^a   Kwiatek, Sebastian ^a  

^a Center for Laser Diagnostics and Therapy   (Poland)

Author keywords

PDD; PDT; Poland

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CHLORINE DERIVATIVE; DIMETHYL SULFOXIDE; ERYTHROPOIETIN; GLYCOLIC ACID; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 12; INTERLEUKIN 18; METALLOPROTEINASE; NANOMATERIAL; NANOPARTICLE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PROTEASOME INHIBITOR; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SUPEROXIDE DISMUTASE;

ACNE; ACTINIC KERATOSIS; ANEMIA; ANTIANGIOGENIC THERAPY; ANTINEOPLASTIC ACTIVITY; AUTOFLUORESCENCE; BASAL CELL CARCINOMA; BLADDER CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER THERAPY; CELL HOMING; CELL PROTECTION; CELLULAR IMMUNITY; CLINICAL RESEARCH; CLINICAL TRIAL; DENDRITIC CELL; DERMATOLOGY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; ELECTROCHEMOTHERAPY; ELECTROPORATION; ELECTROSURGERY; ERYTHROCYTE; FLUORESCENCE IMAGING; GASTROENTEROLOGY; GENOTOXICITY; GYNECOLOGY; HUMAN; IMAGE PROCESSING; IMAGING SYSTEM; IMMUNOCOMPETENT CELL; IONIZING RADIATION; LASER; LIGHT SCATTERING; LIPOSOMAL DELIVERY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; NANOPORE; NEAR INFRARED SPECTROSCOPY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORTHOPEDICS; OTORHINOLARYNGOLOGY; OXIDATIVE STRESS; PHAGOCYTOSIS; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; POLAND; PRECANCER; PRIORITY JOURNAL; PSORIASIS; PULMONOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RADIATION PROTECTION; REVIEW; SKIN ALLERGY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR VASCULARIZATION; VERRUCA VULGARIS; ZETA POTENTIAL;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLAND;

EID: 68449095989     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2009.07.003     Document Type: Review

References (81)

1. Podbielska H., Bindig U., Ulatowska-Jarża A., Hołowacz I., Müller G., and Scheller E.E. Optical properties of sol-gel fiber optic applicators for laser interstitial therapy. Laser Phys 16 5 (2006) 1-11
2. Podbielska, Ulatowska-Jarża A., Bauer J., Wieliczko A., Razik J., and Stre{ogonek}k W. The comparison of photodynamic activity of photolon and protoporphyrine on pathogenic bacteria in vitro. Polish J Environ Studies 15 4A (2006) 147-151
3. In: Podbielska H., Sieroń A., and Stre{ogonek}k W. (Eds). Aspects of Photodynamic Medicine II, Book Series Acta Biomedical Engineering vol. 3, wyd (2008), Indygo Zahir, Wrocław
4. In: Podbielska H., Sieroń A., and Stre{ogonek}k W. (Eds). Aspects of Photodynamic Medicine I, Book Series Acta Biomedical Engineering vol. 2, wyd (2007), Kriotechnika Medyczna, Wrocław
5. In: Podbielska H., Sieroń A., and Stre{ogonek}k W. (Eds). Diagnostyka i terapia fotodynamiczna, Photodynamic diagnostics and therapy (2004), Urban & Partner, Wrocław (in Polish)
6. Ulatowska-Jarża A, Hołowacz I, Razik J, Wieliczko A, Stre{ogonek}k W, Czernielewski L, Podbielska H, New method for decontamination based on photodynamic activity - preliminary in vitro study on Gram-negative bacteria. Proc. of the Symposium on Photonics Technologies for the 7th Framework Program, Oficyna Wyd. Politechniki Wrocławskiej. ISBN 83-7085-970-4; 2006. pp. 324-27.
7. Wysocka K., Buzalewicz I., Wieliczko A., Kowal K., Stre{ogonek}k W., and Podbielska H. Biomaterials with antibacterial activity. Eng Biomater 81-84 (2008) 119-121
8. Bindig U., Ulatowska-Jarża A., Kopaczyńska M., Muller G., and Podbielska H. Investigations on photolon- and porphyrin-doped sol-gel fiberoptic coatings for laser-assisted applications in medicine. Laser Phys 18 1 (2008) s.1-10
9. Podbielska H., Hołowacz I., Bindig U., Ulatowska-Jarża A., Rohde E., and Eicke-Eric S. Interstitial laser coagulation in vitro with sol-gel applicators. Interstycjalna koagulacja laserowa in vitro aplikatorami zol-żelowymi. Med Laser Appl (Elsevier) 21 1 (2006) s.35-43
10. Ulatowska-Jarża A., Zychowicz J., Hołowacz I., et al. Antimicrobial PDT with chlorophyll-derived photosensitizer and semiconductor laser. Med Laser Appl (Elsevier) 21 (2006) s.177-183
11. Podbielska H., Ulatowska-Jarża A., Muller G., Hołowacz I., Bauer J., and Bindig U. Silica sol-gel matrix doped with Photolon molecules for sensing and medical therapy purposes. Biomol Eng 24 5 (2007) s.425-433
12. Boerner E, Bauer J, Szewczyk A, Podbielska H. Laser transillumination of interphalangeal joints of women suffering from rheumatoid diseases. Opt Appl 2007;XXXVII(1-2):153-160.
13. Kubica K., Langner M., and Gabrielska J. The dependence of fluorescein-PE fluorescence intensity on lipid bilayer state. Evaluating the Interaction between the probe and lipid molecules. Cell Mol Biol Lett 8 (2003) 943-954
14. Kral T., Langner M., and Hof M. DNA-spermine and DNA-lipid aggregate formation visualized by fluorescence correlation spectroscopy. Chemotherapy 52 (2006) 196-199
15. Jurkiewicz P., Olżyńska A., Langner M., and Hof M. Headgroup hydration and mobility of DOTAP/DOPC bilayers: a fluorescence solvent relaxation study. Langmuir 22 21 (2006) 8741-8749
16. Kral T., Benda A., Hof M., and Langner M. Some aspects of DNA condensation observed by fluorescence correlation spectroscopy. In: Geddes C.D., and Lakowicz J.R. (Eds). Rev. Fluorescence 2005 vol. 2 (2005), Springer, NY 109-124
17. Woźniacka A., Langner K., McCauliffe D., Sysa-Je{ogonek}drzejowska A., and Langner M. Quantitative evaluation of 52 kD Ro/SS-A intracellular distribution in keratinocytes exposed to UVB radiation. Opt Appl 34 (2004) 77-85
18. Kotulska M. Electrochemotherapy in cancer treatment. Adv Clin Exp Med 16/5 (2007) 601-607
19. Kotulska M., Kubica K., Koronkiewicz S., and Kalinowski S. Modeling the induction of lipid membrane electropermeabilization. Bioelectrochemistry 70 1 (2007) 64-70
20. Kotulska M. Natural fluctuations of an electropore show fractional Lévy stable motion. Biophys J 92 (2007) 2412-2421
21. Kotulska M. Electro-nanopores in the lipid membrane and their application in medicine. Warsaw: Prace Instytutu Biocybernetyki i Inżynierii Biomedycznej; 2007.
22. Dyrka W., Augousti A., and Kotulska M. Ion flux through membrane channels-an enhanced algorithm for the Poisson-Nernst-Planck model. J Comput Chem 29/12 (2008) 1877-1888
23. Olsztyńska-Janus S., Komorowska M., Vrielynck L., and Dupuy N. Vibrational spectroscopic study of l-phenylalanine: effect of pH. Appl Spectrosc 55 7 (2001) s.901-907
24. Komorowska M., Gałwa M., Herter B., and Wesołowska U. Hydration effects under near-infrared radiation. Colloids Surf B 26 3 (2002) 223-233
25. Komorowska M., and Czarnołe{ogonek}ski A. Near-infrared induced membrane surface electrostatic potential, fluorescent measurements. Colloids Surf B 20 4 (2001) s.309-314
26. Olsztyńska-Janus S, Vrielynck L, Komorowska M, Dupuy N. Why light therapy is more effective than thermotherapy in rehabilitation? W: Biomechanika 2001. Materiały XVII konferencji naukowej, Gliwice-Zakopane, 3-6.09.2001. Wrocław: Oficyna Wydaw. PWroc., 2001. Acta Bioeng Biomech 3(Suppl. 2):s.387-91.
27. Chwałek, Kramer G., Wideł M., Ratuszna A., and Habdas J. Photodynamic effect of two water-soluble porphyrins on human malignant melanoma and murine cervical carcinoma in multicellular megacolonies system in vitro. Polish J Med Phys Eng 6 (2000) 185-190
28. Drzewiecka, Urbańska K., Matuszak Z., et al. Tritolylporphyrin dimer as a new potent hydrophobic sensitizer for photodynamic therapy of melanoma. Acta Biochem Pol 48 (2001) 277-282
29. Habdas J., Machura B., Waśkowska A., Mazurak Z., and Ratuszna A. Crystallographic and spectroscopic properties of meso-tetratolyloporhyrin. Ann Polish Chem Soc (2001) 10
30. Szurko A., Kramer-Marek G., Wideł M., Ratuszna A., Habdas J., and Kuś P. Photodynamic effects of two water soluble porphyrins evaluated on human malignant melanoma cells in vitro. Acta Biochim Pol 50 (2003) 1165-1174
31. Kramer-Marek G., Szurko A., Serpa C., et al. Spectroscopic studies and singlet oxygen quantum yields of synthetic porphyrin derivatives-potential novel photodynamic therapy agents. Phys Med XX Suppl. 1 (2004) 46-48
32. Kramer-Marek G., Serpa C., Szurko A., et al. Spectroscopic properties and photodynamic effects of new lipophilic porphyrin derivatives: efficacy, localization and cell death pathways. J Photochem Photobiol B84 (2006) 1-14
33. Idziak D., Pasewicz A., Koloczek J., et al. Molecular structure of 5, 10, 15, 20-tetra(1-naphthyl) porphyrin and 5, 10-di(4-hexadecyloxyphenyl)-15, 20-di(4-pyridyl) porhyrin studied by high-energy X-ray diffraction. Chem Phys Lett 446 (2007) 36-42
34. Pasewicz, Idziak D., Koloczek J., et al. Pair correlation function analysis of 5-(4-hexadecyloxyphe-nyl)-10, 15, 20-tri(4-pirydyl) porphyrin and 5-(4-methoxycarbonylphenyl)-10, 15, 20 tri(4-pirydyl) porphyrin. J Mol Struct 875 (2008) 167-172
35. Szurko A., Rams M., Sochanik A., et al. Spectroscopic and biological studies of a novel synthetic chlorin derivative with prospects for use in PDT. Bioorg Med Chem (2009) [wysłane do druku]
36. Domaniecki J., et al. The use of photodynamic method in the treatment of malignant melanoma and merkel cell carcinoma. IPA'98, Nantes, France.
37. Graczyk A, et al. Progress in photodynamic of tumors diagnosis and treatment. Proceedings of SPIE, vol. 4238; 2000.
38. Graczyk A, et al. Diaminoacid derivatives of protoporfiryne used as photosensitizers in photodynamic method of tumor diagnosis and treatment.
39. Shu Y., et al. Investigation of photo-physical properties of selected diaminoacid protoporphyrin derivatives (PP(AA)2Arg2). I. Determination of quantum yield of fluorescence. Opt Appl XXXIII 2-3 (2003)
40. Shu Y., et al. Investigation of photo-physical properties of selected diaminoacid protoporphyrin derivatives (PP(AA)2Arg2). II. Determination of singlet oxygen FD. Opt Appl XXXIII 2-3 (2003)
41. Bombalska A., and Graczyk A. Interaction of protoporphyrin IX and its derivatives with benzodiazepine receptor. Photodiagn Photodyn Ther (2009) 6
42. Korbelik M., Krosl G., Krosl J., and Dougherty G.J. Role of host lymphoid populations in the response of mouse emt6 tumour to photodynamic therapy. Cancer Res 56 (1996) 5647-5652
43. de Vree W.J.A., Essers M.C., de Bruijn H.S., Star W.M., Koster J.F., and Sluite W. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res 56 (1996) 2908-2911
44. Golab J., Wilczynski G., Zagozdzon R., et al. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br J Cancer 82 (2000) 1485-1491
45. Jalili A., Makowski M., Switaj T., et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 10 (2004) 4498-4508
46. Golab J., Olszewska D., Mroz P., et al. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin Cancer Res 8 (2002) 1265-1270
47. Makowski M., Nowis D., and Golab J. Cytoprotective mechanisms in photodynamic therapy. In: Uzdensky A. (Ed). Photodynamic therapy at the cellular level (2007), Research Signpost, Kerala 97-113
48. Golab J., Nowis D., Skrzycki M., et al. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem 278 (2003) 407-414
49. Makowski M., Grzela T., Niderla J., et al. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. Clin Cancer Res 9 (2003) 5417-5422
50. Gomer C.J., Luna M., Ferrario A., and Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem Photobiol 53 (1991) 275-279
51. Nowis D., Legat M., Grzela T., et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 25 (2006) 3365-3374
52. Kocanova S., Buytaert E., Matroule J.Y., et al. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 12 (2007) 731-741
53. Nowis D., and Golab J. Photodynamic therapy and oxidative stress. In: Hamblin M., and Mroz P. (Eds). Advances in photodynamic therapy: basic, translational, and clinical (2008), Artech House, Boston, London 151-178
54. Szokalska A., Makowski M., Nowis D., et al. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res 69 (2009) 4235-4243
55. Sieroń A., Adamek M., Kawczyk-Krupka A., Mazur S., and Ilewicz L. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med 32 (2003) 330-336
56. Sieroń A., Namysłowski G., Misiołek M., Adamek M., and Kawczyk-Krupka A. Kliniczna odpowiedź po zastosowaniu terapii fotodynamicznej w leczeniu zmian przednowotworowych i zaawansowanych raków głowy i szyi. Otolaryngol Pol 57 4 (2003) 501-504
57. Niepsuj K., Niepsuj G., Cebula W., et al. Autofluorescence endoscopy for detection of high-grade dysplasia in short-segment Barrett's esophagus. Gastrointest Endosc 58 5 (2003) 715-719
58. Szyguła M., Wojciechowski B., Adamek M., et al. Fluorescent diagnosis of urinary bladder cancer-a comparison of two diagnostic modalities. Photodiagn Photodyn Ther 1 (2004) 23-26
59. Jalili A., Makowski M., Świtaj T., et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 10 (2004) 4498-4508
60. Olejek A, Rembielak-Stawecka B, Kozak-Darmas I, Biniszkiewicz T, Sieroń A. Diagnostyka i terapia fotodynamiczna w ginekologiii - aktualny stan wiedzy. Ginekol Pol. T.75(3):228-34.
61. Latocha M., Piława B., Dudek J., et al. Free radicals in melanotic human melanoma and human colon adenocarcinoma cells after photodynamic therapy. Phys Med XX Suppl. 1 (2004) 61-63
62. Senczenko W., Drzazga Z., Sieroń A., Szyguła M., and Adamek M. Measurement of disposition of intensivity of laser radiation in PDT-optimal conditions for therapy. Phys Med XX Suppl. 1 (2004) 58-60
63. Szyguła M., Wojciechowski B., Adamek M., et al. Photodynamic vs. autofluorescent diagnosis of urinary bladder using Xillix Life System. Phys Med XX Suppl. 1 (2004) 55-57
64. Sieroń A, Adamek M, Biniszkiewicz T, et al. Diagnostyka fluorescencyjna i terapia fotodynamiczna w ośrodku wielospecjalistycznym - sześcioletnie doświadczenia własne. Pol Arch Med Wew 2004;T.112, Materiały XXXV Zjazdu TIP: 339-46.
65. Sieroń A, Adamek M, Wiczkowski A, Dyla Ł, Mazur S, Wierucka-Młynarczyk B. Photodynamic destruction of Porphyromonas gingivalis induced by delta-aminolaevulinic acid. Prog Biomed Opt Imag 2004;5(28) [Proc. SPIE vol. 5610 218-223, 2003 druk].
66. Sieroń A., Pietrusa A., Szyguła M., et al. Zastosowanie metod fotodynamicznych w urologii. Urol Pol 57 4 (2004) 16-20
67. Szyguła M., Pietrusa A., Adamek M., et al. Combined treatment of urinary bladder cancer with the use of photodynamic therapy (PDT) and subsequent BCG-therapy: a pilot study. Photodiagn Photodyn Ther 1 3 (2004) 241-246
68. Sieroń A., Kawczyk-Krupka A., Adamek M., et al. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of malignant skin tumors. Photodiagn Photodyn Ther 1 (2004) 311-317
69. Adamek M., Kawczyk-Krupka A., Mostowy A., et al. Topical ALA-PDT modifies neutrophils' chemiluminescence, lymphocytes' interleukin-1beta secretion and serum level of transforming growth factor beta 1 in patients with nonmelanoma skin malignancies. A clinical study. Photodiagn Photodyn Ther 2 1 (2005) 65-72
70. Biniszkiewicz T., Olejek A., Kozak-Darmas I., and Sieroń A. Therapeutic effects of 5-ALA-induced photodynamic therapy in vulvar lichen sclerosus. Photodiagn Photodyn Ther 2 2 (2005) 157-160
71. Latos W., Zieleźnik W., Sieroń-Stołtny K., et al. Planoepithelial papilloma of the esophagus detected in 5 patients in own material of 2582 endoscopies in 2004. Gastroenterol Pol 12 5 (2005) 1-4
72. Sieron A., Gibinski P., Pustelny T., et al. Optical biopsy using spectral camera in BCC and oral leukoplakia. Photodiagn Photodyn Ther 5 December (4) (2008) 271-275 [Epub 2008 November 8]
73. Sieroń A., Kościarz-Grzesiok A., Waśkowska J., et al. The role of autofluorescence diagnostics in the oral mucosa diseases. Photodiagn Photodyn Ther 5 September (3) (2008) 182-186 [Epub 2008 October 31]
74. Lipiński M., Markowski M., and Różański W. The value of photodynamic diagnosis (PDD) in identifying carcinoma In situ (Cis) of urinary bladder. Clin Exp Med Lett 49 1 (2008) 55-57
75. Lipiński M., and Jeromin L. Comparison of the bladder tumour antigen test with photodynamic diagnosis in patients with pathologically confirmed recurrent superficial urinary bladder tumours. BJU Int 89 (2002) 757-759
76. Lipiński M., and Jeromin L.M. Photodynamic Laser therapy in refractory transitional cell carcinoma of urinary bladder-early results. Med Laser Appl 18 (2003) 173-174
77. Lipiński M., and Jeromin L.M. Experiences in the use of photodynamic method in the diagnosis of superficial urinary bladder tumours. Urologia XI 2 (2005) 17-21
78. Lipiński M., and Jeromin L.M. Photodynamic therapy of superficial urinary bladder tumours. Urologia XI 4 (2005) 21-26
79. Lipiński M., and Jeromin L.M. Over 5 years experience of photodynamic diagnosis (PDD) in superficial urinary bladder tumours (BT). BJU Int 90 Suppl. 2 (2002) 199
80. Lipiński M., and Jeromin L.M. Early results in photodynamic laser therapy of superficial urinary bladder tumours. BJU Int 90 Suppl. 2 (2002) 144
81. Jeromin L., Peszyński-Drews C., and Lipiński M. Photodynamic therapy of bladder tumors with new photosensitizer-photolon pilot study. Acta Bio-Opt Inform Med 10 1-2 (2004) 21